AG POLICY NEWS
Brazil Studying Retaliation Against US
Thu Oct 3, 2013 06:01 PM CDT

SAO PAULO (Dow Jones) -- Brazil's government has created a special task force to study possible trade retaliation against the U.S. over a lingering dispute involving American subsidies to cotton growers, the country's National Trade Council said Thursday.

The council, known as Camex, said in a statement that the government will also send a letter to the U.S. president's special trade representative "expressing Brazil's indignation over suspension of cotton payments" to it.

The issue stems from a 2004 World Trade Organization ruling that found U.S. subsidies to cotton growers to be illegal under international trade agreements.

The ...

Quick View
  • Enlist Cotton Approved USDA has made its final decision to deregulate Dow AgroScience's Enlist cotton trait, which means...
  • Market Moves Weaning and preconditioning top the list of aggravating and expensive chores for most ranchers. C...
  • Ask The Mechanic Ask the Mechanic answers the question about how VW and German engineering was able to get by with...
  • Senior Partners - 4 Except for family sales, seller financing virtually vanished after the farm crisis of the 1980s w...
  • PNW Ag Hit by Historic Drought In addition to problems with the Northwestern wheat crop, cattle are also being adversely affecte...
  • RFS Deadline Nears With the deadline to file comments on the proposed Renewable Fuel Standard volumes to strike at m...
  • Woodbury: Farm Family Business Agendas don't always lead to immediate decisions, but can still cement your family unity.
  • Multi-Year Losses Spur Concern The recent price rally offered growers a welcome opportunity to price 2014 and 2015 crops, but it...
  • Ask the Vet The vet says my calf had Mannheimia. What is that?
Related News Stories
Washington Insider -- Friday
Ag Policy Blog
Washington Insider -- Thursday
States Want WOTUS Delayed
Washington Insider -- Wednesday
Washington Insider -- Tuesday
RFS Deadline Nears
Ag Policy Blog
Washington Insider -- Monday
No Senate Biotech Bill Until Fall